Skip to main content
Erschienen in: Skeletal Radiology 9/2017

03.06.2017 | Case Report

Tuberous sclerosis and its rare association with macrodactyly and fibrous hamartomas

verfasst von: Y. S. Lim, M. S. Mak, P. C. Mohan

Erschienen in: Skeletal Radiology | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

Tuberous sclerosis complex is a genetic disease that results in abnormal cellular proliferation and hamartoma growths in multiple organ systems. However, macrodactyly and subcutaneous fibrous harmatomas are very uncommon associations with this disease. We see these rare manifestations in our case report of a 16-year-old female with tuberous sclerosis complex and discuss the imaging findings and pathogenetics of these manifestations. Through this, our report aims to expand the known clinical spectrum of features seen in tuberous sclerosis and aid in its diagnosis.
Literatur
1.
Zurück zum Zitat Webb DW, Clarke A, Fryer A, Osborne JP. The cutaneous features of tuberous sclerosis: a population study. Br J Dermatol. 1996;135:1.CrossRefPubMed Webb DW, Clarke A, Fryer A, Osborne JP. The cutaneous features of tuberous sclerosis: a population study. Br J Dermatol. 1996;135:1.CrossRefPubMed
2.
Zurück zum Zitat Yates JR, Maclean C, Higgins JN, et al. The tuberous sclerosis 2000 study: presentation, initial assessments and implications for diagnosis and management. Arch dis Child. 2011;96:1020.CrossRefPubMed Yates JR, Maclean C, Higgins JN, et al. The tuberous sclerosis 2000 study: presentation, initial assessments and implications for diagnosis and management. Arch dis Child. 2011;96:1020.CrossRefPubMed
3.
Zurück zum Zitat Sharma S, Sankhyan N, Gulati S, et al. Macrodactyly and fibrous hamartoma in a child with tuberous sclerosis complex. J Child Neurol. 2011;26:95–8.CrossRefPubMed Sharma S, Sankhyan N, Gulati S, et al. Macrodactyly and fibrous hamartoma in a child with tuberous sclerosis complex. J Child Neurol. 2011;26:95–8.CrossRefPubMed
4.
Zurück zum Zitat Lew PP, Ngai SS, Hamidi R, et al. Imaging of disorders affecting the bone and skin. Radiographics. 2014;34(1):197–216.CrossRefPubMed Lew PP, Ngai SS, Hamidi R, et al. Imaging of disorders affecting the bone and skin. Radiographics. 2014;34(1):197–216.CrossRefPubMed
6.
Zurück zum Zitat Sahoo B, Handa S, Kumar B. Tuberous sclerosis with macrodactyly. Pediatr Dermatol. 2000;17:463–5.CrossRefPubMed Sahoo B, Handa S, Kumar B. Tuberous sclerosis with macrodactyly. Pediatr Dermatol. 2000;17:463–5.CrossRefPubMed
7.
Zurück zum Zitat Aldrich CS, Hong CH, Groves L, Olsen C, Moss J, Darling TN. Acral lesions in tuberous sclerosis complex: insights into pathogenesis. J Am Acad Dermatol. 2010;63(2):244–51. Aldrich CS, Hong CH, Groves L, Olsen C, Moss J, Darling TN. Acral lesions in tuberous sclerosis complex: insights into pathogenesis. J Am Acad Dermatol. 2010;63(2):244–51.
8.
Zurück zum Zitat Ghalli FE. Macrodactyly in tuberous sclerosis. Pediatr Dermatol. 2001;18(4):364–5. Ghalli FE. Macrodactyly in tuberous sclerosis. Pediatr Dermatol. 2001;18(4):364–5.
9.
Zurück zum Zitat Sasongko TH, Ismail NFD, Nik Mohd Ariff NAM, Zabidi-Hussin ZAMH. Macrodactyly and poliosis in tuberous sclerosis complex. Jpn J Clin Oncol. 2014;44(11):1130 Sasongko TH, Ismail NFD, Nik Mohd Ariff NAM, Zabidi-Hussin ZAMH. Macrodactyly and poliosis in tuberous sclerosis complex. Jpn J Clin Oncol. 2014;44(11):1130
10.
Zurück zum Zitat Shin AY, Garay AA. Unilateral insensate macrodactyly secondary to tuberous sclerosis in a child. Am J Orthop (Belle Mead NJ). 1997;26(1):30–2. Shin AY, Garay AA. Unilateral insensate macrodactyly secondary to tuberous sclerosis in a child. Am J Orthop (Belle Mead NJ). 1997;26(1):30–2.
11.
Zurück zum Zitat Tung HE, Shih SL. Tuberous sclerosis with rare presentation of macrodactyly. Pediatr Radiol. 2009;39(8):878. Tung HE, Shih SL. Tuberous sclerosis with rare presentation of macrodactyly. Pediatr Radiol. 2009;39(8):878.
12.
Zurück zum Zitat Kousseff BG. Tuberous sclerosis and macrodactyly. Dysmorph Clin Genet. 1989;3:5–7. Kousseff BG. Tuberous sclerosis and macrodactyly. Dysmorph Clin Genet. 1989;3:5–7.
13.
Zurück zum Zitat Ortonne J-P, Jeune R, Fulton R, Thiovolet J. Primary localised gigantism and tuberous sclerosis. Arch Dermatol. 1982;118:878–9. Ortonne J-P, Jeune R, Fulton R, Thiovolet J. Primary localised gigantism and tuberous sclerosis. Arch Dermatol. 1982;118:878–9.
14.
Zurück zum Zitat Wallis CE, Beighton PH. Tuberous sclerosis with macrodactyly. Dysmorph Clin Genet. 1989;3:2–4. Wallis CE, Beighton PH. Tuberous sclerosis with macrodactyly. Dysmorph Clin Genet. 1989;3:2–4.
15.
Zurück zum Zitat Zaremba J. Tuberous sclerosis: a clinical and genetic investigation. J Ment Defic Res. 1968;12:63–80. Zaremba J. Tuberous sclerosis: a clinical and genetic investigation. J Ment Defic Res. 1968;12:63–80.
17.
Zurück zum Zitat Luttrell LM, Daaka Y, Lefkowitz RJ. Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr Opin Cell Biol. 1999;11:177.CrossRefPubMed Luttrell LM, Daaka Y, Lefkowitz RJ. Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr Opin Cell Biol. 1999;11:177.CrossRefPubMed
18.
Zurück zum Zitat Tee AR, Fingar DC, Manning BD, et al. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci USA. 2002;99:13571.CrossRefPubMedPubMedCentral Tee AR, Fingar DC, Manning BD, et al. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci USA. 2002;99:13571.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Benvenuto G, Li S, Brown SJ, et al. The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination. Oncogene. 2000;19:6306.CrossRefPubMed Benvenuto G, Li S, Brown SJ, et al. The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination. Oncogene. 2000;19:6306.CrossRefPubMed
20.
Zurück zum Zitat Wienecke R, König A, DeClue JE. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity. J Biol Chem. 1995;270:16409.CrossRefPubMed Wienecke R, König A, DeClue JE. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity. J Biol Chem. 1995;270:16409.CrossRefPubMed
21.
Zurück zum Zitat Gao X, Zhang Y, Arrazola P, et al. Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat Cell Biol. 2002;4:699.CrossRefPubMed Gao X, Zhang Y, Arrazola P, et al. Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat Cell Biol. 2002;4:699.CrossRefPubMed
22.
Zurück zum Zitat Han H, Lim G, You C. A large infiltrating fibrous hamartoma of infancy in the abdominal wall with rare associated tuberous sclerosis. Pediatr Radiol. 2009;39:743–6.CrossRefPubMed Han H, Lim G, You C. A large infiltrating fibrous hamartoma of infancy in the abdominal wall with rare associated tuberous sclerosis. Pediatr Radiol. 2009;39:743–6.CrossRefPubMed
Metadaten
Titel
Tuberous sclerosis and its rare association with macrodactyly and fibrous hamartomas
verfasst von
Y. S. Lim
M. S. Mak
P. C. Mohan
Publikationsdatum
03.06.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Skeletal Radiology / Ausgabe 9/2017
Print ISSN: 0364-2348
Elektronische ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-017-2683-9

Weitere Artikel der Ausgabe 9/2017

Skeletal Radiology 9/2017 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.